Trial intelligence / Profile preview

Remimazolam vs Propofol for Postoperative Myocardial Injury in Elderly Patients

NCT07725185Enrolling by invitation

Sponsor
The Affiliated Hospital of Jiaxing University
Start
Aug 2026
Primary completion
Jun 2028
Countries
1
01

Overview

Randomised, double-blind trial of remimazolam in Myocardial injury (2 arms), sponsored by The Affiliated Hospital of Jiaxing University. Primary endpoint: High-sensitivity cardiac troponin T. Started Aug 2026; status: enrolling by invitation.

02

Drugs

remimazolam
03

Conditions

Myocardial injury

Beyond the preview

Go deeper on NCT07725185.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07725185.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call